Non-genetic risk factors for holoprosencephaly
β Scribed by Candice Y. Johnson; Sonja A. Rasmussen
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 139 KB
- Volume
- 154C
- Category
- Article
- ISSN
- 1552-4868
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Holoprosencephaly (HPE) is a congenital defect of the brain characterized by incomplete cleavage of the embryonic forebrain into left and right hemispheres. Although a substantial proportion of cases of HPE can be attributed to genetic abnormalities, the etiology in many cases remains unknown, with nonβgenetic risk factors believed to be important contributors. Due to the low birth prevalence of this defect, it has proven difficult to conduct studies of sufficient size to identify risk factors with certainty. This article provides a summary of nonβgenetic risk factors for HPE that have been investigated in case reports and case series, animal studies, and epidemiologic studies, including maternal illnesses, therapeutic and nonβtherapeutic exposures, nutritional factors, and sociodemographic factors. The article also highlights challenges in study design and further areas for research to better understand the etiology of HPE. Published 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract The wide variation in cerebral and facial phenotypes and the recognized etiologic heterogeneity of holoprosencephaly (HPE) contribute to the observed interβstudy heterogeneity. High lethality during the early stages of embryonic and fetal development makes HPE detection age dependent. B
Holoprosencephaly is a developmental field defect manifested by a spectrum of abnormalities of the forebrain and midface. Approximately 50% of holoprosencephaly cases are associated with a cytogenetic abnormality or a monogenic syndrome. Suggested risk factors for the remaining 50% of cases have bee
A population-based case-control study was conducted in Shanghai, China, to investigate the associations between exposures to various non-dietary variables and risk of nasopharyngeal carcinoma (NPC). A total of 935 NPC patients and 1,032 community controls were included. Active cigarette smoking was